</s><s> the 9-valent HPV vaccine ( 9vHPV ) was approved by the food and drug administration on 10/10/2014. 
 this vaccine targets types 6, 11, 16, and 18, the types targeted by the quadrivalent vaccine ( 4vhpv ), as well as five additional types, types 31, 33, 45, 52, and 58. the 9vhpva can be used for routine vaccination of females aged 11 or 12 years and females through age 26 years who have not been vaccinated previously or who have completed the 3-dose series or 4vHPv or 2vhpV or 4 or 2.9vhpvs can be combined with 4 or 4.5 doses of 2.5-dose 4.0-dose 2.4-dose 1.0.1.1 to provide a total of 9 doses of 4.1-dose 3.0 for routine vaccine of males aged 11 and 12 years or for vaccination of men who have sex with men and immunocompromised persons through 26 years if not vaccinated previously. </s>